Wegovy vs Other Weight Loss Medications
5 mins read
Wegovy is a once-weekly prescription medicine containing semaglutide that is used alongside a reduced-calorie diet and increased physical activity for long-term weight management.
Other weight loss medications include Tirzepatide, liraglutide, naltrexone/bupropion, and orlistat, each with different mechanisms, dosing schedules, benefits, and potential side effects.
Clinical evidence shows that semaglutide and Tirzepatide can support significant weight loss, although individual results vary.
The most suitable medication depends on factors such as medical history, treatment goals, side-effect tolerance, lifestyle, cost, and availability.
Weight loss medications are increasingly used alongside lifestyle changes for people who need additional support with obesity or overweight and related health risks. Among these medicines, the Wegovy injection has received considerable attention because it contains semaglutide, a GLP-1 receptor agonist administered once weekly. However, it is not the only prescription option.
So, how does Wegovy compare with other weight loss medications? The Wegovy injection is an effective option for weight management, but the most suitable medication depends on the individual's health profile, treatment goals, tolerability, and preferences.
Wegovy injections contain semaglutide, which mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). It can help regulate appetite, increase feelings of fullness, and reduce food intake. It is prescribed alongside a reduced-calorie diet and increased physical activity [1].
Clinical trials have shown that semaglutide can produce substantial weight loss when combined with lifestyle changes. However, individual results can vary depending on factors such as adherence, starting weight, diet, physical activity, and underlying health conditions.
The Wegovy injection is therefore not simply a short-term appetite suppressant. Weight management treatment is generally intended as part of a longer-term approach, with continued monitoring and lifestyle support.
Several prescription medicines can be used for weight management. They do not work in exactly the same way, and their effectiveness, dosing schedules, and side-effect profiles differ [2].
Medication | Main Mechanism | Typical Dosing Pattern | Key Considerations |
|---|---|---|---|
Wegovy (semaglutide) | GLP-1 receptor agonist | Once-weekly injection | Strong evidence for weight loss; gastrointestinal side effects are common |
Tirzepatide | GIP and GLP-1 receptor agonist | Once-weekly injection | Can produce substantial weight loss; gastrointestinal effects may occur |
Liraglutide | GLP-1 receptor agonist | Daily injection | Effective option but requires more frequent dosing |
Naltrexone/bupropion | Acts on brain pathways involved in appetite and food intake | Oral medication | May not be suitable for people with certain medical conditions |
Orlistat | Reduces dietary fat absorption | Oral medication with meals | Gastrointestinal effects can occur, particularly with high-fat meals |
Tirzepatide is one of the closest alternatives to the Wegovy injection because it is also administered once weekly. It works on two hormone pathways, glucose-dependent insulinotropic polypeptide (GIP) and GLP-1, whereas semaglutide primarily targets GLP-1.
Clinical studies have found that Tirzepatide can produce greater average weight loss than semaglutide in some patient groups [3]. However, this does not mean it is automatically the better choice for everyone. Medical history, side effects, availability, cost, and individual treatment response should all be considered.
Liraglutide is another GLP-1 receptor agonist. Unlike the Wegovy weight loss injection, which is administered once weekly, liraglutide is generally taken as a daily injection.
Both medicines can help reduce appetite and support weight loss, but the difference in dosing frequency may influence treatment preferences. Some people may find weekly administration more convenient, while others may have different considerations based on their medical needs [4].
Not all weight loss medicines require injections. Naltrexone/bupropion is an oral medication that acts on brain pathways involved in appetite and food cravings. Orlistat works differently by reducing the absorption of dietary fat in the digestive system [5].
These medications may be appropriate for selected patients, particularly those who prefer oral treatment. However, they have their own contraindications, potential side effects, and considerations that need to be reviewed with a healthcare professional.
It can be tempting to compare medications based solely on the amount of weight people lose in clinical trials. However, average results do not necessarily predict how an individual will respond.
The Wegovy weight loss injection can support clinically meaningful weight loss for many eligible patients, but response varies. Some people may achieve greater results with another medication, while others may find that semaglutide provides a suitable balance between effectiveness, convenience, and tolerability.
Treatment effectiveness should therefore be considered alongside safety, convenience, affordability, and long-term sustainability.
Like other prescription medicines, the Wegovy injection for weight loss can cause side effects. Gastrointestinal symptoms are among the most commonly reported and may include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and bloating.
These effects may be more noticeable when treatment is started or when the dose is increased. Gradually increasing the dose as prescribed can help the body adjust to treatment. However, not everyone is suitable for semaglutide. A healthcare professional should review a person's medical history, current medications, and potential risks before treatment begins.
Weight loss medication should not replace healthy eating, physical activity, adequate sleep, and other lifestyle measures. Instead, medication can form part of a broader weight management plan.
It is also important to recognise that weight regain can occur after stopping treatment. This is why discussions about long-term management should take place before starting the Wegovy injection or another weight loss medication [6].
The goal is not simply to lose weight quickly but to develop a sustainable approach that supports overall health and helps maintain improvements over time.
There is no single weight loss medication that is ideal for everyone. A healthcare professional may consider:
The Wegovy treatment may be suitable for someone looking for a once-weekly treatment with evidence supporting meaningful weight loss. Tirzepatide may be considered when greater average weight reduction is a priority and it is medically appropriate. Other medications may be preferable when injections are unsuitable or when oral treatment better matches a person's preferences.
The Wegovy injection is an established prescription option for long-term weight management, but it should be considered alongside other evidence-based treatments rather than viewed as a universal solution.
Semaglutide offers once-weekly dosing and can support significant weight loss, while Tirzepatide, liraglutide, naltrexone/bupropion, and orlistat provide alternative approaches with different mechanisms, benefits, and limitations.
Ultimately, choosing a weight loss medication involves more than comparing average weight-loss results. A personalised medical assessment can help determine which treatment best fits an individual's health needs, lifestyle, preferences, and long-term goals. Patients should also discuss potential side effects, monitoring, and treatment duration, among others.
